The table below shows TG THERAPEUTICS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$204.92M
$161.71M
$141.15M
$120.86M
$83.88M
$73.47M
Cost of revenue
$33.51M
$28.09M
$18.94M
$15.54M
$9.34M
$8.30M
Gross profit
-
-
-
-
-
-
R&D
$48.40M
$40.88M
$31.78M
$46.36M
$20.14M
$17.56M
TGTX annual revenue (10-K history)
TG THERAPEUTICS, INC. reported annual revenue of $616.29M for fiscal year 2025. That is up 87.3% from $329.00M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $152.00K (FY 2016) to $616.29M. Figures come from the company's audited annual reports as filed with the SEC.
